Notwithstanding numerous setbacks, a number of MDM2 inhibitors have now progressed into late-phase scientific progress. New procedures have also been developed to enhance the efficacy of MDM2 inhibitors and to mitigate their on-concentrate on toxicity. With this critique, we summarize the development and problems in the development of the MDM2 https://johns998phy9.wikiannouncement.com/user